Cat#: | RP-1632H |
Product Name: | Recombinant Human VEGFR3 / FLT4 Protein (His Tag) |
Synonym: | FLT-4,FLT-41,FLT41,LMPH1A,PCL,VEGFR-3,VEGFR3 |
Description: | A DNA sequence encoding the extracellular domain (Met 1-Ile 776) of human VEGFR3 (NP_002011.2) was expressed with a C-terminal polyhistidine tag. |
Source: | Human Cells |
Predicted N Terminal: | Tyr 25 & Ser 473 |
Molecular Characterization: | The recombinant human VEGF R3 consists of 763 amino acids and predicts a molecular mass of 86 kDa. As a result of glycosylation, rhVEGFR3 migrates as an approximately 130 kDa in non-reduced SDS-PAGE. |
Purity: | Greater than 97 % as determined by SDS-PAGE |
Endotoxin: | < 1.0 EU per ug of the protein as determined by the LAL method |
Bioactivity: | Please contact us for detailed information |
Formulation: | Lyophilized from sterile PBS, pH 7.4 |
Stability: | Recombinant Proteins are stable for up to 1 year from date of receipt at -70℃ |
Reconstitution: | Please see related COA for specific instructions. |
Storage: | Avoid repeated freeze-thaw cycles. In lyophilized state for 1 year (4-8℃); Upon reconstitution under sterile conditions for 2 weeks (4-8℃) or 3 months (-20℃ to -70℃). |